Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study. - Feldt-Rasmussen, Ulla; Hughes, Derralynn; Sunder-Plassmann, Gere; Shankar, Suma; Nedd, Khan; Olivotto, Iacopo; Ortiz, Damara; Ohashi, Toya; Hamazaki, Takashi; Skuban, Nina; Yu, Julie; Barth, Jay A.; et al. (Molecular Genetics & Metabolism, 2020)